Gains Made in Lung Cancer Survival Millington TN

In the past two decades, survival rates for advanced lung cancer patients in the United States have improved modestly, a new study has found. Researchers analyzed data on more than 100,000 patients diagnosed with stage 4 non-small cell lung cancer (NSCLC) between 1990 and 2005. The patient information was in the U.S. National Cancer Institute's Surveillance, Epidemiology and End Results database.

Wolf River Family Footcare PLLC
(901) 381-2800
8081 Hwy 51 N
Millington, TN

Data Provided by:
Millington Foot Clinic
(901) 432-1666
8081 Hwy 51 N
Millington, TN

Data Provided by:
East Memphis Chiropractic
(901) 202-9216
4954 William Arnold Rd
Memphis, TN

Data Provided by:
Robert Wallace
(901) 347-8290
7945 Wolf River Blvd
Germantown, TN
Specialties
Cosmetic Surgery
Insurance
Medicare Accepted: No
Workmens Comp Accepted: No
Accepts Uninsured Patients: No
Emergency Care: No


Data Provided by:
Jones Eye Care
(901) 754-2020
2075 Exeter Rd
Germantown, TN

Data Provided by:
Big Creek Animal Hospital
(901) 872-2281
6543 Navy Rd
Millington, TN

Data Provided by:
Steven T Martin, MD
(901) 371-9040
4901 Raleigh Common Dr
Memphis, TN
Business
Cardiovascular Physicians of Memphis
Specialties
Cardiology

Data Provided by:
Allen K. Raich DPM
(901) 432-1408
920 Estate Dr
Memphis, TN

Data Provided by:
Neumon Goshorn
(901) 756-3838
7705 Poplar Avenue
Germantown, TN
Specialties
Cosmetic Surgery
Insurance
Medicare Accepted: No
Workmens Comp Accepted: No
Accepts Uninsured Patients: No
Emergency Care: No


Data Provided by:
John Claude LaBarreare
(901) 872-6868
4785 Cuba Millington Rd
Millington, TN
Specialty
Family Practice

Data Provided by:
Data Provided by:

Gains Made in Lung Cancer Survival

Provided By:

WEDNESDAY, Dec. 2 (HealthDay News) -- In the past two decades, survival rates for advanced lung cancer patients in the United States have improved modestly, a new study has found.

Researchers analyzed data on more than 100,000 patients diagnosed with stage 4 non-small cell lung cancer (NSCLC) between 1990 and 2005. The patient information was in the U.S. National Cancer Institute's Surveillance, Epidemiology and End Results database.

The study found that one-year overall survival increased from 13.2 percent in 1990 to 19.4 percent in 2005, while two-year overall survival increased from 4.5 percent to 7.8 percent.

The researchers said the improved survival rates may come from changes in the management of advanced NSCLC over the past two decades, including new chemotherapy agents and regimens, increased use of salvage chemotherapy and the introduction of molecularly targeted therapies.

"Although the development of several new agents led to a statistically significant survival improvement between 1990 and 2005, it is sobering that the one-year survival has improved by only 6 percent during this time," study author Dr. Daniel Morgensztern, of the Washington University School of Medicine, said in a news release from the International Association for the Study of Lung Cancer. "Real progress can only be achieved with a better understanding of tumor biology and development of [new] therapies."

The study is published in the December issue of the Journal of Thoracic Oncology.

More information

The U.S. National Cancer Institute has more about lung cancer.

SOURCE: International Association for the Study of Lung Cancer, news release, Dec. 1, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

© 1996-2010

Contemporary Media
460 Tennessee Street, 2nd Floor | Memphis, TN 38103
Visit our other sites: Memphis Magazine | Memphis Parent | Memphis Business Quarterly
Powered by Foundation